Science Stories
Our transformative team culture
The team talks about the culture at Boehringer Ingelheim
Search
285 Result(s)
September 27, 2023
World-renowned top scientists and companies take the stage at Boehringer Ingelheim’s second Transforming Science Day
Cancer
Transforming Cancer Care
By working with a range of stakeholders, including patients, advocacy organizations, researchers, academics and more, we can make a meaningful impact in transforming the lives of people with cancer.
Human Health Innovation
Transforming Science Day: Europe Register Now!
Science & Innovation
Transforming Science Day
Lung Cancer
Our goal of transforming DLL3-positive carcinomas
Our progress in developing a potential targeted immunotherapy for DLL3-positive small cell lung cancer and neuroendocrine carcinomas.
Swine
Transforming pig farming: how AI helps detect respiratory disease in pigs and more
Watch how our digital sound analytical tool ensures animal health and quality protein production
Science Stories
Transforming the Treatment of Lung Fibrosis through Lung Repair and Regeneration
Matthew Thomas, Head of Immunology & Respiratory Research, Germany, describes how translational science approaches are informing our lung fibrosis research
What Our Partners Say
Our Partners: ViraTherapeutics
Lisa Egerer, COO and Patrik Erlmann, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
September 16, 2020
Successful IT transformation recognized: Boehringer Ingelheim wins Digital Leader Award 2020
Company Culture
The purpose of helping others
How a career as Professional Services Vet has transformed Trent’s life.
March 01, 2022
Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
March 07, 2019
Novel antibody shows potential to transform treatment of rare form of psoriasis
OUR FOCUS
Accountability, Agility, Intrapreneurship
How we work together
Science Stories
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’
Carine Boustany, SVP, Site Head Discovery Research US discusses Boehringer Ingelheim’s research approach in fibrosis.
Corporate Profile
Board of Managing Directors
As a family-owned company Boehringer Ingelheim is governed by the Board of Managing Directors composed of five members. Read more about their respective responsibilities.
Sites Around the World
Koropi
For more than 45 years, the company has been producing pharmaceuticals in its production facility in Koropi, Greece.
Science Stories
What does it mean to drug cancer’s “big four”?
Learn how Darryl McConnell & his team are tackling one of the biggest scientific conundrums.
Pets
“It’s about saving lives”
Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America
Science Stories
Innovation in Medicinal Chemistry: Unlocking Unsolved Diseases
From AI to PROTACs, Darryl McConnell and Jürgen Mack explain how our teams leverage cutting-edge approaches aiming to bring ‘undruggable’ targets within reach.
Retinal Diseases
A Clear Vision
As experts in Retinal Health, we aim to transform the retinal health landscape by developing novel treatments and technologies, especially where nothing currently exists.
Retinal Diseases
Our Vision for Retinal Health
Visual impairment and blindness have a profound and devastating impact on the lives of the affected person, their families and society as a whole.
Human Health Partnering Interests
Immunology
Science Focus
Innovation in CNS Disease Research
Diseases of the central nervous system represent one of the major public health challenges today.
Metabolic Diseases
Innovation in Cardio-Renal-Metabolic Diseases
Cardiovascular, renal and metabolic diseases are connected conditions that can amplify each other. We are dedicated to delivering innovation for people living with these diseases both now, and for future generations.